GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Beginning Cash Position

Genesystem Co (XKRX:363250) Beginning Cash Position : ₩5,623 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Beginning Cash Position?

Genesystem Co's Beginning Cash Position for the quarter that ended in Mar. 2025 was ₩5,623 Mil.

Genesystem Co's quarterly Beginning Cash Position declined from Sep. 2024 (₩8,125 Mil) to Dec. 2024 (₩7,907 Mil) and declined from Dec. 2024 (₩7,907 Mil) to Mar. 2025 (₩5,623 Mil).

Genesystem Co's annual Beginning Cash Position declined from Dec. 2022 (₩25,631 Mil) to Dec. 2023 (₩16,837 Mil) and declined from Dec. 2023 (₩16,837 Mil) to Dec. 2024 (₩9,090 Mil).


Genesystem Co Beginning Cash Position Historical Data

The historical data trend for Genesystem Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Beginning Cash Position Chart

Genesystem Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
Get a 7-Day Free Trial 802.05 9,057.73 25,630.73 16,836.89 9,089.76

Genesystem Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,089.76 12,746.64 8,125.32 7,907.30 5,623.24

Genesystem Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Genesystem Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Genesystem Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Genesystem Co Business Description

Traded in Other Exchanges
N/A
Address
200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028
Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co Headlines

No Headlines